MINT-INDOMETHACIN
MINT PHARMACEUTICALS INC
Quick answers
Is there a shortage of MINT-INDOMETHACIN in Canada?
No. There is no current shortage of MINT-INDOMETHACIN 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TEVA-INDOMETHACIN
TEVA CANADA LIMITED
PRO-INDO 25 CAP 25MG
PRO DOC LIMITEE
INDOCID CAP 25MG
MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.
NU-INDO CAP 25MG
NU-PHARM INC
RHODACINE - CAP 25MG
RHODIAPHARM INC
Other Products
PRO-INDO 50 CAP 50MG
PRO DOC LIMITEE
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02461811
Strength
25MG
Dosage Form
Capsule
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430